Galderma Laboratories, L.Pal Competitors, Revenue, Alternatives and Pricing

Claim your profile


Dallas, TX USA
Total Funding:N/A
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Galderma Laboratories, L.Pal's estimated annual revenue is currently $62.5M per year.(?)
  • Galderma Laboratories, L.Pal's estimated revenue per employee is $201,000

Employee Data

  • Galderma Laboratories, L.Pal has 311 Employees.(?)
  • Galderma Laboratories, L.Pal currently has 1 job openings.

CollaGenex Pharmaceuticals, Inc. is a specialty pharmaceutical company currently focused on providing innovative medical therapies to the dental and dermatology markets. The Company's lead product, Periostat, was approved by the FDA in September 1998 and is the first and only pharmaceutical to treat periodontal disease by inhibiting the enzymes that destroy periodontal support tissues.